Introduction
Human T cell leukemia virus, type I (HTLV-I),' is an exogenous human retrovirus that is tropic for T cells bearing the OKT4 surface phenotype although other cell types can be infected (1) (2) (3) . HTLV-I was first isolated from a patient with adult T cell leukemia/lymphoma (ATL) in the United States (1) and has been shown to be an etiologic agent of this disease in several parts of the world (2, 4, 5) . In addition, HTLV-I infection has been associated with impairment of immune function; patients with ATL often develop opportunistic infections with agents such as Pneumocystis carinii even before they receive immunosuppressive chemotherapy (5) , and otherwise asymptomatic 1. Abbreviations used in this paper: ATL, adult T cell leukemia/lymphoma; Con A, concanavalin A; EBV, Epstein-Barr virus; E:T, effector to target ratio; FCS, fetal calf serum; HTLV-I, human T cell leukemia virus, type I; IL-2, interleukin 2; LOR, long open reading frame; PBMC, peripheral blood mononuclear cells; PWM, pokeweed mitogen.
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The behavior of HTLV-I in tissue culture mirrors these clinical manifestations. T cells infected with HTLV-I become transformed with increased expression ofinterleukin 2 (IL-2) receptors and a reduction or elimination in their requirement for interleukin 2 (3, 7) . In addition, HTLV-I has been shown to induce alterations in specific T cell functions. After infection with HTLV-I, antigen-specific clones have been observed to lose their requirement for antigen presentation by accessory cells with shared histocompatibility antigens in order to proliferate or to provide help for immunoglobulin (Ig) production (8, 9) . Cytotoxic clones have been shown to lose their cytotoxic function (9) . Finally, T cell lines infected with HTLV-I have been shown to constitutively secrete a variety of lymphokines (10, 1 1) and to proliferate when stimulated with cells bearing any class II histocompatibility antigen (12) . The (Table II ). In the case of line 8.8H 1, however, only 10% of the cells were positive for p19 or p24 on day 36 (at a time when cytotoxic function was lost), and only faint expression of these proteins was noted. Because of this barely detectable expression of viral gag proteins, this line was further studied by Southern blot hybridization to determine whether it indeed contained HTLV-I provirus.
After digestion of DNA from line 8.8H 1 (day 86) with Eco RI, which does not cleave within the HTLV-I genome (21), a single band of -9.5 kilobase (kb) in length was obtained using the pCH-I (pX-env plus pol) HTLV-I probe (Fig. 3) . In contrast, no hybridization was observed to DNA from an EBV-trans- Recent studies have indicated that the OKT3 surface antigen is coexpressed with the T cell antigen receptor (22, 23), and OKT3 antibody has been shown to block the cytotoxic effector function of clone 8.8 (13, 14) . In addition, Hoffman et al. (24) have recently found that the OKT3 murine hybridoma is lysed by cytotoxic T cells, presumably by the binding of OKT3 antibody on the surface of this hybridoma to the OKT3-T cell receptor complex. With this background, the ability ofuninfected and HTLV-I infected 8.8 cells to lyse target cells expressing OKT3 antibody was studied. As shown in Fig. 5 , cytotoxic ac- 1488 Yarchoan, Guo, Reitz, Jr., Maluish, Mitsuya, and Broder (Fig. 7 A) . 
Discussion
This study demonstrates that an OKT4+ T cell clone could simultaneously manifest both specific cytotoxic activity against allogenic targets and help for nonspecific IgG production by autologous B cells when stimulated with the appropriate alloantigen, and that these two functions were differentially affected following infection with HTLV-I. Cytotoxic function was preserved for up to 70 d but was then lost, and this loss was associated with a decreased expression of T3 surface antigen. Help for IgG production became independent of DPw2 antigenic stimulation early after infection with HTLV-I, and this constitutive help remained after the cytotoxic function was lost. While cytotoxic function was eventually lost in these lines, it was preserved with unchanged specificity at least up to 36 d after exposure to MJ tumor cells (Table I) even without additional antigenic stimulation. During this initial period, the clones proliferated rapidly (8.8H3 expanded from 0.3 X 106 cells at the time of HTLV-I exposure to 86 X 106 cells on day 25). This ability to expand a clone with defined cytotoxic activity might potentially have application in such areas as cellular HLA typing (for example of antigens not resolved by available antisera) or the biochemical study of T cell receptor structures; such an approach would particularly be useful in cases where the stimulator antigens were difficult to obtain or where the untransformed clone grew poorly. It should be stressed, however, that the use of such transformed clones should only be undertaken with appropriate biohazard containment and with an awareness of the potential alterations in T cell functions that may be induced by HTLV-I.
After this initial period, clones 8.7 and 8.8 eventually lost their cytotoxic function. A similar loss of function of two cytotoxic clones after transformation with HTLV-I has been observed by Popovic et al. (9) . In the case of 8.7 and 8.8, this loss occurred despite repeated antigenic stimulation, suggesting that a lack of antigenic exposure was not the cause of the loss of function. 1470 Yarchoan, Guo, Reitz, Jr., Maluish, Mitsuya, and Broder (33) . It has been postulated that other T cell genes may similarly be activated by a product of the HTLV-I genome (most likely the LOR protein) (32), and it is possible that the constitutive help observed after HTLV-I infection may be the result ofthe trans-activation of certain T cell products. The failure of the supernatant of 8.8H3 to provide help suggests that direct T cell contact may be required for this helper activity, or that it may be mediated by a factor that is either labile or produced in small amounts.
The present results also have implications in the pathogenesis ofleukemia in persons infected with HTLV-I. Immunologic defense mechanisms, particularly T cell-mediated cytolysis, are considered to play an important role in the surveillance against virally induced tumors (34, 35) , and the ability to evade these defenses is associated with increased viral oncogenicity. Strain 12 of adenovirus, for example, inhibits the expression of class I histocompatibility antigens by infected cells and thus enables them to escape detection by cytotoxic T cells (36) . Moreover, experiments with recombinant plasmids have indicated that this property is associated with increased oncogenicity in immunocompetent animals (37). In the case of HTLV-I, while the virus is acutely transforming in vitro, only 1-2% ofinfected individuals eventually develop leukemia-lymphoma, suggesting that in most persons there is immunologic control of these transformed T cells. As evidence for this control, cytotoxic T cell lines specific for HTLV-I have been derived from asymptomatic carriers of ATL (38) , from a patient with ATL unusually responsive to therapy (39), and from a fraction ofpatients with ATL who have been brought into partial remission (40 
